L3VLUP
ProSign in

CRSP · AMGN in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

CRSPAMGN
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • CRSP
  • AMGN
0102030202120222023202420252026
Holders and value by quarter
QuarterCRSPAMGN
Q3 20204 holders, $763m16 holders, $16.3bn
Q4 20209 holders, $2.0bn19 holders, $14.0bn
Q1 20214 holders, $1.3bn16 holders, $14.5bn
Q2 20214 holders, $1.5bn23 holders, $13.8bn
Q3 20214 holders, $903m24 holders, $11.6bn
Q4 20214 holders, $781m21 holders, $10.4bn
Q1 20226 holders, $696m23 holders, $9.9bn
Q2 20226 holders, $799m28 holders, $9.7bn
Q3 20225 holders, $603m21 holders, $7.9bn
Q4 20226 holders, $369m24 holders, $9.3bn
Q1 20234 holders, $380m22 holders, $8.4bn
Q2 20236 holders, $483m26 holders, $7.4bn
Q3 20234 holders, $354m26 holders, $8.7bn
Q4 20234 holders, $609m24 holders, $8.4bn
Q1 20244 holders, $595m25 holders, $6.7bn
Q2 20245 holders, $480m20 holders, $8.0bn
Q3 20244 holders, $403m21 holders, $8.8bn
Q4 20242 holders, $388m20 holders, $8.2bn
Q1 20253 holders, $414m25 holders, $12.0bn
Q2 20254 holders, $643m20 holders, $10.2bn
Q3 20254 holders, $748m17 holders, $10.4bn
Q4 20251 holders, $552m19 holders, $18.0bn
Q1 20264 holders, $840m15 holders, $21.4bn
Q2 20263 holders, $883m23 holders, $24.9bn
CRSP

Crispr Therapeutics AG

Holders
3
Reported value
$883m
Buyers
15
Sellers
8

Breadth +7 among 91 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP
AMGN

Amgen Inc

Holders
23
Reported value
$24.9bn
Buyers
19
Sellers
13

Breadth +6 among 91 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP

Who holds both, Q2 2026

Among the 24 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only CRSP (1)

ARK Investment Management LLC

Only AMGN (21)

AllianceBernstein LP, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Citadel Advisors LLC, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), Hudson Bay Capital Management LP, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, Neuberger Berman Group LLC, PDT Partners LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Walleye Capital LLC, Wellington Management Group LLP, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →